Tuesday, March 31, 2020
Wall St Journal, Hydroxychloroquine Use in Coronavirus Patients
Here are highlights from an article in the Wall Street Journal written by two doctors for using hydroxychloroquine plus azithromycin for treating people with Covid-19.
“Use this treatment cocktail early, and don’t wait until a patient is on a ventilator in the intensive-care unit.”Read the entire article | Email this article
Friday, March 27, 2020
COVID-19: Far fewer will die than previously predicted according to epidemiologist
UK epidemiologist Neil Ferguson who predicted that 500,000 people in the UK would die from COVID-19, drastically reduced his estimate to 20,000 or less — a 25-fold reduction or more—according to an article on the DailyWire.com.
He also predicted that 2.2 million people in the US would die from COVID-19, which also would be a dramatical overestimate.Read the entire article | Email this article
Wednesday, March 18, 2020
Hydroxychloroquine + azithromycin eliminated COVID-19 virus in 95% of patients in 6 days
Hydroxychloroquine (200 mg three times a day) eliminated the coronavirus COVID-19 in 75% of patients after 6 days, while hydroxychloroquine plus the antibiotic azithromycin (500 mg on day 1 followed by 250 mg per day for the next four days) eliminated the virus in 95% of patients after 6 days according to a study done by French biologist and Infectious Disease Specialist, Prof. Didier Raoult, MD, PhD as noted in an article on Medscape.Read the entire article | Email this article
Monday, March 16, 2020
It would be a medical mistake not to give hydroxychloroquine for COVID-19 notes Prof. Didier Raoult
Thursday, March 05, 2020
Niacin lowers risk of heart attack or dying from a heart attack by an average of 25%
Niacin lowers risk of stroke by an average of 26%
Niacin raises HDL by an average of 20%
Niacin lowers LDL by an average of 16%
Niacin lowers triglycerides by an average of 20%
Niacin lowers C-reactive protein (CPR) by an average of 24%
Extended-release niacin (1500 to 2000 mg per day) lowers levels of C-reactive protein (CRP) by an average of 24% in people starting with higher levels of Lp(a)—starting levels of 92 mg/dL versus 54 mg/dL—according to a study from Russia.
Elevated levels of C-reative protein—above 2 mg/dL—are associated with an increased risk of heart and stroke as noted by the Mayo Clinic.
Note: I prefer immediate-release niacin to extended-release niacin. In the 1980’s there were reports of some liver problems with extended-release niacin, and earlier studies showing benefits of niacin used immediate-release niacin, not extended-release.Read the entire article | Email this article
Sunday, March 01, 2020
DRUG COMPANY LIES
The great placebo scandal
QUICKLINKS AND VIEW OPITONS
QUOTE OF THE DAY
Books by Larry Hobbs available on Amazon
© Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.